Creating on a legacy of groundbreaking developments in medicine and science, Weill Cornell Drugs now launched an formidable $1.5 billion campaign – with additional than $750 million presently elevated – that will harness rising biomedical improvements to provide exemplary care to people and create enduring modify in medicine.
The “We’re Transforming Medicine” campaign is the largest in Weill Cornell Medicine’s heritage and its to start with marketing campaign in decades to advance and synergize all 3 institutional missions: to treatment, discover and educate. Exemplifying Cornell’s mission of executing the best good, the new marketing campaign will instill this critical worth in the next technology of medical professionals and experts, who will shape an revolutionary and equitable long run of medication.
Powering the “We’re Switching Medicine” marketing campaign is $215 million in foundational gifts from many of the institution’s most lengthy-standing benefactors. In 2019, for the duration of the campaign’s peaceful phase, a guide reward from The Starr Foundation, chaired by Weill Cornell Medication Board of Fellows member Maurice R. Greenberg, in partnership with items from The Weill Family Foundation, established by Joan and Sanford I. Weill, marketing campaign co-chair and Board of Fellows chairman emeritus, and other generous donors together totaled $160 million. This established a recreation-changing scholarship system that offers debt-no cost training to health care students in financial have to have.
A $55 million reward in 2020 from Board of Fellows vice chair and campaign co-chair Jeffrey Feil and the Feil household will support the development of a new college student home corridor four blocks from the institution’s most important campus, which will even further boost Weill Cornell Medicine’s student expertise.